Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uwe Hobohm

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|August 27, 2009
Toward general prophylactic cancer vaccinationUwe Hobohm
Journal of Molecular Medicine (Berlin, Germany)|March 22, 2002
The Lower Rhine Society for natural history and medicine in BonnUwe Hobohm
Nucleic Acids Research|September 29, 2009
PDBselect 1992-2009 and PDBfilter-selectSven Griep, Uwe Hobohm
Integrative Cancer Therapies|May 22, 2016
Coley's Lessons Remembered: Augmenting Mistletoe TherapyMaurice Orange, Uwe Reuter, Uwe Hobohm
Cancer Immunology, Immunotherapy : CII|July 9, 2013
Mistletoe lectin has a shiga toxin-like structure and should be combined with other Toll-like receptor ligands in cancer therapyClaudia Maletzki, Michael Linnebacher, Rajkumar Savai, et al.
Translational Oncology|February 10, 2018
Safety of Therapeutic Fever Induction in Cancer Patients Using Approved PAMP DrugsUwe Rudolf Max Reuter, Ralf Oettmeier, Uwe Hobohm
Critical Reviews in Immunology|June 11, 2008
Pathogen-associated molecular pattern in cancer immunotherapyUwe Hobohm, John L Stanford, John M Grange
FEBS Letters|May 19, 2004
ADP-ribosylation factor (ARF)-like 7 (ARL7) is induced by cholesterol loading and participates in apolipoprotein AI-dependent cholesterol exportThomas Engel, Aloys Lueken, Günther Bode, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|August 27, 2009
Toward general prophylactic cancer vaccinationUwe Hobohm
Journal of Molecular Medicine (Berlin, Germany)|March 22, 2002
The Lower Rhine Society for natural history and medicine in BonnUwe Hobohm
Nucleic Acids Research|September 29, 2009
PDBselect 1992-2009 and PDBfilter-selectSven Griep, Uwe Hobohm
Integrative Cancer Therapies|May 22, 2016
Coley's Lessons Remembered: Augmenting Mistletoe TherapyMaurice Orange, Uwe Reuter, Uwe Hobohm
Cancer Immunology, Immunotherapy : CII|July 9, 2013
Mistletoe lectin has a shiga toxin-like structure and should be combined with other Toll-like receptor ligands in cancer therapyClaudia Maletzki, Michael Linnebacher, Rajkumar Savai, et al.
Translational Oncology|February 10, 2018
Safety of Therapeutic Fever Induction in Cancer Patients Using Approved PAMP DrugsUwe Rudolf Max Reuter, Ralf Oettmeier, Uwe Hobohm
Critical Reviews in Immunology|June 11, 2008
Pathogen-associated molecular pattern in cancer immunotherapyUwe Hobohm, John L Stanford, John M Grange
FEBS Letters|May 19, 2004
ADP-ribosylation factor (ARF)-like 7 (ARL7) is induced by cholesterol loading and participates in apolipoprotein AI-dependent cholesterol exportThomas Engel, Aloys Lueken, Günther Bode, et al.
Pageof 1